Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Peiying Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4989-6384; OpenAlex author ID A5003693436. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. The Preclinical Effects and Mechanisms of Biofield Therapy on Pancreatic Cancer Cell Growth and Metastasis. Co-author DOI 10.1002/cam4.71726↗
  2. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Co-author DOI 10.1007/s10620-023-07931-3↗
  3. Fraction B From Catfish Epidermal Secretions Kills Pancreatic Cancer Cells, Inhibits CD44 Expression and Stemness, and Alters Cancer Cell Metabolism. Last author DOI 10.3389/fphar.2021.659590↗
  4. PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Last author DOI 10.1007/s10637-014-0190-6↗
  5. Response to: Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer? First author DOI 10.1007/s10637-015-0208-8↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daoyan Wei · 3 shared papers, 2021–2026 · strength 0.56
  2. Lorenzo G. Cohen · 1 shared paper, 2026 · strength 0.26
  3. Liang Wang · 1 shared paper, 2023 · strength 0.18
  4. Yi Liu · 1 shared paper, 2023 · strength 0.18
  5. Xiangsheng Zuo · 1 shared paper, 2023 · strength 0.18
  6. Robert S. Bresalier · 1 shared paper, 2023 · strength 0.18
  7. Robert Alan Newman · 2 shared papers, 2015 · strength 0.15
  8. Jassim Mohammad Al‐Hassan · 1 shared paper, 2021 · strength 0.12
  9. Yong Pan · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.